Regeneron Pharmaceuticals
REGN
REGN
966 hedge funds and large institutions have $49.5B invested in Regeneron Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 147 funds opening new positions, 366 increasing their positions, 303 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
966
Holders Change
+47
Holders Change %
+5.11%
% of All Funds
16.86%
Holding in Top 10
18
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.88%
% of All Funds
0.31%
New
147
Increased
366
Reduced
303
Closed
88
Calls
$1.04B
Puts
$1.25B
Net Calls
-$209M
Net Calls Change
+$251M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$420M |
| 2 |
Harris Associates
Chicago,
Illinois
|
+$230M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$158M |
| 4 |
HM
HealthCor Management
New York
|
+$106M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$105M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$669M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$489M |
| 3 |
BlackRock
New York
|
-$344M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$283M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$202M |